183 related articles for article (PubMed ID: 29225479)
21. Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
Anand S; Bhati G; Gurram R; Gnanasekaran S; Kate V; Pottakkat B; Kalayarasan R
J Gastrointest Cancer; 2021 Jun; 52(2):659-665. PubMed ID: 32607960
[TBL] [Abstract][Full Text] [Related]
22. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy.
Kim TG; Park W; Kim H; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Kang KM
Tumori; 2019 Oct; 105(5):434-440. PubMed ID: 30117371
[TBL] [Abstract][Full Text] [Related]
23. An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.
Sun Y; Huang Z; Chi P
Int J Clin Oncol; 2020 Jul; 25(7):1299-1307. PubMed ID: 32274615
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.
Miyashita M; Sasano H; Tamaki K; Hirakawa H; Takahashi Y; Nakagawa S; Watanabe G; Tada H; Suzuki A; Ohuchi N; Ishida T
Breast Cancer Res; 2015 Sep; 17(1):124. PubMed ID: 26341640
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Huang CM; Huang MY; Tsai HL; Huang CW; Su WC; Chang TK; Chen YC; Li CC; Wang JY
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572816
[TBL] [Abstract][Full Text] [Related]
26. Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8
Tanaka R; Kimura K; Eguchi S; Tauchi J; Shibutani M; Shinkawa H; Ohira GO; Yamazoe S; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M
Anticancer Res; 2020 May; 40(5):2881-2887. PubMed ID: 32366438
[TBL] [Abstract][Full Text] [Related]
27. Body composition parameters combined with blood biomarkers and magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Yang J; Deng Q; Chen Z; Chen Y; Fu Z
Front Oncol; 2023; 13():1242193. PubMed ID: 38074647
[TBL] [Abstract][Full Text] [Related]
28. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
[TBL] [Abstract][Full Text] [Related]
29. Immune Cell Infiltrates and Neutrophil-to-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
Sánchez-Canteli M; Juesas L; Redin E; Calvo A; López F; Astudillo A; Montuenga LM; García-Pedrero JM; Rodrigo JP
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33923066
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis.
Hamid HKS; Davis GN; Trejo-Avila M; Igwe PO; Garcia-Marín A
Surg Oncol; 2021 Jun; 37():101556. PubMed ID: 33819850
[TBL] [Abstract][Full Text] [Related]
32. The Possible Role of Anti- and Protumor-Infiltrating Lymphocytes in Pathologic Complete Response in Early Breast Cancer Patients Treated with Neoadjuvant Systemic Therapy.
Geršak K; Geršak BM; Gazić B; Klevišar Ivančič A; Drev P; Ružić Gorenjec N; Grašič Kuhar C
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835488
[TBL] [Abstract][Full Text] [Related]
33. Predictive and prognostic significance of CD8
Al-Saleh K; Abd El-Aziz N; Ali A; Abozeed W; Abd El-Warith A; Ibraheem A; Ansari J; Al-Rikabi A; Husain S; Nabholtz JM
Oncol Lett; 2017 Jul; 14(1):337-344. PubMed ID: 28693173
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies.
Zhao J; Meisel J; Guo Y; Nahta R; Hsieh KL; Peng L; Wei Z; O'Regan R; Li X
Breast Cancer Res Treat; 2020 Oct; 183(3):599-606. PubMed ID: 32715443
[TBL] [Abstract][Full Text] [Related]
35. Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer.
Abe N; Matsumoto H; Takamatsu R; Tamaki K; Takigami N; Uehara K; Kamada Y; Tamaki N; Motonari T; Unesoko M; Nakada N; Zaha H; Yoshimi N
Virchows Arch; 2020 May; 476(5):701-709. PubMed ID: 31873876
[TBL] [Abstract][Full Text] [Related]
36. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
[TBL] [Abstract][Full Text] [Related]
37. Prognostic effect of preoperative neutrophil-lymphocyte ratio is related with tumor necrosis and tumor-infiltrating lymphocytes in hepatocellular carcinoma.
Ha SY; Choi S; Park S; Kim JM; Choi GS; Joh JW; Park CK
Virchows Arch; 2020 Dec; 477(6):807-816. PubMed ID: 32483662
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.
Miyakita H; Sadahiro S; Suzuki T; Chan LF; Ogimi T; Okada K; Yamamoto S; Kajiwara H
Oncology; 2020; 98(12):869-875. PubMed ID: 32799200
[TBL] [Abstract][Full Text] [Related]
40. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
Hirahara T; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Okubo K; Uenosono Y; Ishigami S; Natsugoe S
BMC Cancer; 2019 Jul; 19(1):672. PubMed ID: 31286873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]